Zhichao Li
Shandong University of Traditional Chinese Medicine(CN)Nanchang University(CN)Sun Yat-sen University(CN)Guangdong Medical College(CN)Chinese Academy of Sciences(CN)Shanghai Chest Hospital(CN)First Affiliated Hospital of Jiangxi Medical College(CN)Shandong Tumor Hospital(CN)Second Affiliated Hospital of Nanchang University(CN)Shanghai Pulmonary Hospital(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)Tang Du Hospital(CN)Affiliated Hospital of Shandong University of Traditional Chinese Medicine(CN)Institute of Geographic Sciences and Natural Resources Research(CN)Shandong First Medical University(CN)Shenzhen Second People's Hospital(CN)University of Chinese Academy of Sciences(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Angiogenesis and VEGF in Cancer, Ferroptosis and cancer prognosis, Lung Cancer Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility(2020)221 cited
- → Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice(2011)187 cited
- → Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening(2020)134 cited
- → The trans-omics landscape of COVID-19(2021)133 cited
- → Patient-derived organoid (PDO) platforms to facilitate clinical decision making(2021)133 cited
- → Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats(2016)120 cited